患者来源头颈鳞癌类器官评估碳离子相对X线的差异效应
该研究用5株头颈鳞癌患者来源类器官(PDTO)比较碳离子与X线的生物学效应,采用活力检测、细胞周期分析和新型类器官克隆形成实验(OFA)。活力检测显示碳离子杀伤效果优于X线,相对生物学效应(RBE)为1.14至1.94;OFA显示碳离子在X线抵抗株的RBE为6.54、在X线敏感株为4.23。结论提示OFA可作为评估碳离子等放疗模式的替代实验,碳离子可能克服部分患者的光子放射抵抗。
要点
- 碳离子对头颈鳞癌类器官的杀伤优于X线,活力检测RBE为1.14至1.94。
- OFA显示碳离子在X线抵抗株RBE为6.54,高于X线敏感株的4.23。
- OFA可作为在PDTO上评估碳离子等放疗模式的替代实验。
核心结论
- OFA可作为评估碳离子等不同放疗模式在PDTO模型上效应的替代实验。
- 结果提示碳离子可能克服部分患者对光子的放射抵抗,改善头颈鳞癌管理。
研究设计与样本
- 研究纳入5株从头颈鳞癌患者建立的PDTO,暴露于碳离子和X线并比较处理反应。
- 比较方法包括活力检测、细胞周期分析和新设计的类器官克隆形成实验OFA。
主要发现
- 活力检测显示碳离子较X线有更好的细胞杀伤效果,RBE范围为1.14至1.94。
- OFA显示碳离子在X线抵抗PDTO株的RBE为6.54,在X线敏感株为4.23。
- 细胞周期分析和活力检测确认了上述结果。
临床怎么用
- PDTO联合OFA可用于体外比较碳离子与X线的效应,辅助评估放射抵抗。
- 碳离子可能作为克服光子放射抵抗的放疗选择,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and purpose, Conventional radiotherapy, based on the use of X-rays, remains a standard treatment modality for advanced Head and Neck Squamous Cell Carcinoma (HNSCC), either as a standalone approach or in combination with surgery and/or chemotherapy. Despite its widespread use, approximately 50% of HNSCC patients ultimately experience locoregional recurrence, underscoring the critical need to improve the therapeutic efficacy of radiotherapy. Heavy particles such as carbon ions could lead to better efficiency in treating HNSCC with less side effects. Patient-Derived Tumor Organoids (PDTO) are new 3D in vitro model close to original tumor. However, cancer cell inactivation and/or death induced by carbon ions have not been assessed on PDTO so far or even compared to X-ray. Methods and Materials, Five PDTO lines established from HNSCC patients were exposed to carbon ions and to X-rays and their response to treatments were compared using viability assay, cell cycle analysis and a newly designed clonogenic assay named Organoid Forming Assay (OFA). Results, Viability assays showed a better cell killing effect of carbon ions over X-Rays with a relative biological effect (RBE) ranging from 1.14 to 1.94. OFA revealed a better efficiency of carbon ions over X-rays in a X-ray-resistant PDTO line (RBE at 6.54) compared to a X-ray-sensitive one (RBE at 4.23). These results were confirmed using cell cycle analysis and viability assay. Conclusions, OFA could be a new alternative assay to evaluate different radiotherapy modalities including carbon ions on PDTO models. These results suggest that PDTO may be used to study effects of carbon ions and carbon ions could overcome radioresistance to photons observed in some patients and lead to improvement in management of HNSCC patients.
引用
- Perréard M, Florent R, Divoux J, et al. Use of patient-derived tumor organoids from head and neck squamous cell carcinoma for the evaluation of the differential effect of carbon ions over X-rays. Radiother Oncol. 2025. PMID: 40617441. doi:10.1016/j.radonc.2025.111026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。